BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6449072)

  • 1. Antitumor effect of neocarzinostatin entrapped in neutral, negatively and positively charged liposomes against Ehrlich solid carcinoma.
    Shinozawa S; Araki Y; Oda T
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):181-4. PubMed ID: 6449072
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor effect of neocarzinostatin entrapped in liposomes.
    Shinozawa S; Araki Y; Oda T
    Gan; 1980 Feb; 71(1):107-11. PubMed ID: 6445846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse.
    Shinozawa S; Araki Y; Oda T
    Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activities and physicochemical properties of pre-neocarzinostatin and UV-irradiated neocarzinostatin.
    Iseki S; Koide Y; Ebina T; Ishida N
    J Antibiot (Tokyo); 1980 Jan; 33(1):110-3. PubMed ID: 6445350
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydrogen bromide adduct of neocarzinostatin chromophore: one of the stable derivatives of native neocarzinostatin chromophore.
    Edo K; Akiyama-Murai Y; Saito K; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Sep; 41(9):1272-4. PubMed ID: 2972669
    [No Abstract]   [Full Text] [Related]  

  • 6. [Targeting effect of transferrin-neocarzinostatin conjugate by receptor-mediated endocytosis].
    Urushizaki I
    Nihon Rinsho; 1989 Jun; 47(6):1423-31. PubMed ID: 2528008
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of the antitumor effect of illudin S by including it into liposomes.
    Shinozawa S; Tsutsui K; Oda T
    Experientia; 1979 Aug; 35(8):1102-3. PubMed ID: 477894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mercaptoethanol in vitro DNA degradation by neocarzinostatin.
    Ishida R; Takahashi T
    Cancer Res; 1978 Aug; 38(8):2617-20. PubMed ID: 149591
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-tumor effect of transferrin-neocarzinostatin conjugate which is taken up by cells with receptor medicated endocytosis].
    Kohgo Y; Nishisato T; Kondo H; Matsumoto S; Kato J; Tsushima N; Niitsu Y; Urushizaki I
    Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):641-6. PubMed ID: 3016123
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.
    Cervato G; Viani P; Galatulas I; Bossa R; Cestaro B
    Anticancer Res; 1986; 6(6):1287-90. PubMed ID: 3813484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular interaction and in vitro antitumor activity of lipophilic mitomycin C prodrugs.
    Matsumoto S; Hayashi Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3784-91. PubMed ID: 3124966
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of julimycin B-II.
    Matsuura S; Shiratori O; Harada Y; Katagiri K
    J Antibiot (Tokyo); 1967 Sep; 20(5):282-6. PubMed ID: 5630771
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)].
    Nagao T; Kammura O; Nozaki H; Takahashi Y; Niiya K
    Rinsho Ketsueki; 1976 Aug; 17(8):838-43. PubMed ID: 144198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preoperative administration of antineoplastic agents against gastric cancer. V. Clinical evaluation of combined chemotherapy with neocarzinostatin (NCS) and 5-fluorouracil (combined NF therapy) (author's transl)].
    Okada K; Kitade F; Mabuchi A; Osawa N; Yasuda M; Kawashima Y; Yagi A; Yamada S; Sakuramoto K; Okajima K; Kita R; Sumida T; Kasagawa O
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):834-41. PubMed ID: 159328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
    Köhnlein W; Jung G
    Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local chemotherapy of malignant glioma. Intra-tumoral administration of neocarzinostatin].
    Uemura S; Matsukado Y; Kuratsu J; Sonoda H; Ohtsuka T; Yoshioka S; Yamada M
    Neurol Med Chir (Tokyo); 1986 Jun; 26(6):468-74. PubMed ID: 2430207
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on surgical adjuvant chemotherapy for colorectal cancer and administration of neocarzinostatin into the lumen of the colon or rectum using a double balloon catheter and iontophoresis.
    Akao S
    Nihon Geka Hokan; 1981 Jan; 50(1):67-82. PubMed ID: 6456709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunopotentiating effect of a chemotherapeutic agent (Neocarzinostatin). Accumulation of macrophages during intrathecal administration].
    Kuratsu JI; Matsukado Y; Uemura S; Sueyoshi N
    Neurol Med Chir (Tokyo); 1983 Nov; 23(11):856-9. PubMed ID: 6201761
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer.
    Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Okajima K
    Bull Osaka Med Sch; 1981 Oct; 27(2):65-78. PubMed ID: 6295535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.